Suppr超能文献

埃塞俄比亚北部接受抗逆转录病毒治疗的青少年和成人中HIV病毒学未抑制情况及与未抑制相关的因素:一项回顾性研究

HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study.

作者信息

Desta Abraham Aregay, Woldearegay Tewolde Wubayehu, Futwi Nesredin, Gebrehiwot Gebrecherkos Teame, Gebru Goyitom Gebremedhn, Berhe Asfawosen Aregay, Godefay Hagos

机构信息

Tigray Health Research Institute, P. O. Box: 1547, Mekelle, Tigray, Ethiopia.

Tigray Regional Health Bureau, Mekelle, Tigray, Ethiopia.

出版信息

BMC Infect Dis. 2020 Jan 2;20(1):4. doi: 10.1186/s12879-019-4732-6.

Abstract

BACKGROUND

Despite the benefits of Antiretroviral Therapy (ART), there is a growing concern of treatment failure. This study aimed to assess viral non suppression rate and factors associated with HIV viral non suppression among adolescents and adults on ART in Northern Ethiopia.

METHODS

A retrospective cross sectional study was done on 19,525 study subjects. All the data in the database of Tigray Health Research Institute was exported to Microsoft excel 2010 and then data verification and filtration were done before exporting to STATA 14.0 for analysis. Generalized Estimating Equation (GEE) logistic regression was used for statistical modeling of viral non suppression.

RESULTS

A total of 5153 (26.39%; 95%CI (25.77%, 27.02)) patients had no viral suppression despite being on ART. Being male (AOR = 1.27, 95% CI: 1.18, 1.37), 15-19 years of age (AOR = 4.86, 95%CI: 3.86, 6.12), patients from primary hospital (AOR = 1.26, 95%CI: 1.05, 1.52), WHO staging II (AOR = 1.31, 95%CI: 1.10, 1.54), poor ART adherence level (AOR = 2.56, 95%CI: 1.97, 3.33), fair ART adherence level (AOR = 1.61, 95%CI: 1.36, 1.90), baseline CD-4 count of < 200 cells/micro liter (AOR = 1.33, 95%CI: 1.14, 1.54), recent CD-4 count of < 200 cells/micro liter (AOR = 3.78, 95%CI: 3.34, 4.27), regimen types: 1c (AZT-3TC-NVP) (AOR = 1.32, 95%CI: 1.22, 1.44), 2 h (TDF-3TC-ATV/R) (AOR = 1.79, 95%CI: 1.27, 2.52) and declined immunological responses after ART initiation (AOR = 1.45, 95%CI: 1.30, 1.61) were significantly associated with viral non-suppression.

CONCLUSIONS

The virological non suppression was high which makes it less likely to achieve the third 90 UNAIDS target. Being male, patients with WHO staging II and poor ART adherence level were significantly associated with viral non suppression. Therefore, intensive adherence support and counseling should be provided. It is also a high time to determine the antiretroviral drugs resistance pattern given the fact that a large number of patients had virological non suppression.

摘要

背景

尽管抗逆转录病毒疗法(ART)有诸多益处,但对治疗失败的担忧日益增加。本研究旨在评估埃塞俄比亚北部接受ART治疗的青少年和成年人中病毒未被抑制的发生率以及与HIV病毒未被抑制相关的因素。

方法

对19525名研究对象进行了一项回顾性横断面研究。提格雷健康研究所数据库中的所有数据被导出到Microsoft excel 2010,然后在导出到STATA 14.0进行分析之前进行数据验证和筛选。使用广义估计方程(GEE)逻辑回归对病毒未被抑制进行统计建模。

结果

尽管接受了ART治疗,但共有5153名(26.39%;95%CI(25.77%,27.02%))患者病毒未被抑制。男性(调整后比值比[AOR]=1.27,95%CI:1.18,1.37)、15 - 19岁(AOR = 4.86,95%CI:3.86,6.12)、来自基层医院的患者(AOR = 1.26,95%CI:1.05,1.52)、世界卫生组织(WHO)临床分期II期(AOR = 1.31,95%CI:1.10,1.54)、ART依从性差(AOR = 2.56,95%CI:1.97,3.33)、ART依从性一般(AOR = 1.61,95%CI:1.36,1.90)、基线CD4细胞计数<200个/微升(AOR = 1.33,95%CI:1.14,1.54)、最近CD4细胞计数<200个/微升(AOR = 3.78,95%CI:3.34,4.27)、治疗方案类型:1c(齐多夫定-拉米夫定-奈韦拉平)(AOR = 1.32,95%CI:1.22,1.44)、2h(替诺福韦-拉米夫定-阿扎那韦/利托那韦)(AOR = 1.79,95%CI:1.27,2.52)以及ART启动后免疫反应下降(AOR = 1.45,95%CI:1.30,1.61)与病毒未被抑制显著相关。

结论

病毒学未被抑制的情况很严重,这使得实现联合国艾滋病规划署的第三个90目标的可能性降低。男性、WHO临床分期II期患者以及ART依从性差与病毒未被抑制显著相关。因此,应提供强化的依从性支持和咨询。鉴于大量患者存在病毒学未被抑制的情况,现在也是确定抗逆转录病毒药物耐药模式的时候了。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e428/6941313/b61bec118b37/12879_2019_4732_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验